Iloneoside, an antimalarial pregnane glycoside isolated from Gongronema latifolium leaf, potentiates the activity of chloroquine against multidrug resistant Plasmodium falciparum

Simple item page
dc.contributor.authorAdebayo, J. O.
dc.contributor.authorCeravolo, I. P.
dc.contributor.authorGyebi, G.A.
dc.contributor.authorOlorundare, O. E.
dc.contributor.authorBabatunde, A. S.
dc.contributor.authorPenna-Coutinho, J. P.
dc.contributor.authorKoketsu, M.
dc.contributor.authorKrettli, A. U.
dc.date.accessioned2022-11-07T13:57:34Z
dc.date.available2022-11-07T13:57:34Z
dc.date.issued2022-03
dc.description.abstractThe rapid spread of drug resistant malaria parasites has necessitated the search for novel antimalarials and chemosensitizers capable of reversing drug resistance in the parasites. A number of studies have revealed the resistance reversal activities of pregnane glycosides and the antimalarial activity of a pregnane glycoside obtained from Gongronema species. However, the pregnane (2) and pregnane glycosides (1, 3–4) isolated from Gongronema latifolium leaf have not been evaluated for these activities. This study was therefore carried out to evaluate the antiplasmodial and chloroquine resistance reversal activities of a pregnane and three pregnane glycosides isolated from G. latifolium leaf in vitro. The compounds were evaluated for their inhibitory activities against P. falciparum 3D7 (a chloroquine-sensitive strain) and P. falciparum W2 (a chloroquine-resistant clone) in vitro. The activities of chloroquine in separate combination with each of the compounds against P. falciparum W2 were also evaluated. Moreover, the interaction of the active compounds (1 and 4) with selected P. falciparum proteins (PfProteins) were evaluated in silico. The results revealed that only 1 and 4 were active against P. falciparum 3D7 and P. falciparum W2. Also, 2 and 3 did not exhibit chloroquine resistance reversal activity. Activity of chloroquine against P. falciparum W2 was potentiated by 1 by 3200% at concentrations higher than 0.625 μg/mL. Also, 1 and 4 demonstrated similar binding patterns and higher binding tendencies to the selected PfProteins compared to chloroquine. Thus, 1 (iloneoside) is an antimalarial pregnane glycoside which can potentiate the activity of chloroquine against multidrug resistant P. falciparum.en_US
dc.identifier.citationAdebayo, J. O., Ceravolo, I. P., Gyebi, G. A., Olorundare, O. E., Babatunde, A. S., Penna-Coutinho, J. P., Koketsu, M., & Krettli, A. U. (2022). Iloneoside, an antimalarial pregnane glycoside isolated from Gongronema latifolium leaf, potentiates the activity of chloroquine against multidrug resistant Plasmodium falciparum. Molecular and biochemical parasitology, 249, 111474.en_US
dc.identifier.urihttps://uilspace.unilorin.edu.ng/handle/20.500.12484/7817
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectGongronema latifolium Leaf, Pregnane glycosides, Antiplasmodial activity, Chloroquine resistance reversalen_US
dc.titleIloneoside, an antimalarial pregnane glycoside isolated from Gongronema latifolium leaf, potentiates the activity of chloroquine against multidrug resistant Plasmodium falciparumen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Adebayo et al 2022. Iloneoside, an antimalarial pregnane glycoside.pdf
Size:
7.01 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections